| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/16/2006 | US20060036073 Neurotrophic and neuroprotective peptides |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035959 e.g. (dibenzofuran-4-yl)-(3,5-dichlorophenylamino)acetic acid; glycine B antagonist on the NMDA receptor complex for regulating the calcium balance; analgesic,antiinflammatory, antidepressant, anxiolytic agent, neurodegenerative diseases; chronic and neuropathic pain |
| 02/16/2006 | US20060035948 e.g. 6-nitro-4-[N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran; protecting neuronal cells from oxidative stress induced cell death by iron or by hydrogen peroxide; antihypoxic agent, neuroprotectant |
| 02/16/2006 | US20060035917 Inhibits morphine tolerance caused by repeated administration of morphine, while not affecting the analgesic effects of morphine upon a single administration |
| 02/16/2006 | US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035894 Phenyl[(2S)-4-(phenylmethyl)morpholin-2-yl]methanol; anxiolytic, antidepressant, cognition activator; rise in the concentration of that neurotransmitter within the synaptic cleft; psycological disorders, attention deficit hyperactivity disorder, obesity; deprotection |
| 02/16/2006 | US20060035885 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives |
| 02/16/2006 | US20060035873 Methods for inducing apolipoprotein e secretion |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035819 Novel molecule |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035809 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035303 JNK3 modulators and methods of use |
| 02/16/2006 | US20060035268 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 02/16/2006 | US20060035263 DRG11-responsive (DRAGON) gene family |
| 02/16/2006 | US20060034917 Coating of tablet cores |
| 02/16/2006 | US20060034911 New oral immediated release dosage form |
| 02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 02/16/2006 | US20060034858 A beta or an immunogenic fragment thereof presented by a virus or bacteria as part of an immunogenic composition effective to induce an immunogenic response comprising antibodies against A beta |
| 02/16/2006 | US20060034855 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 02/16/2006 | US20060034826 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 02/16/2006 | US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs |
| 02/16/2006 | DE20321153U1 Transdermal therapeutic system containing the analgesic fentanyl, comprising penetration accelerator-free drug-containing adhesive matrix of acrylate copolymer with hydroxyethyl acrylate and vinyl acetate units |
| 02/16/2006 | DE102004039326A1 Treatment of neurodegenerative diseases, specifically Alzheimer's disease and Down syndrome, uses a chemical/biological substance which inhibits fatty acid amide hydrolase without inhibiting cyclooxygenase-1 and/or 2 |
| 02/16/2006 | DE102004034682A1 Verkürztes Verfahren zur Herstellung von chiralem Lobelin Shortened process for the preparation of chiral lobeline |
| 02/16/2006 | DE102004033785A1 Beruhigende Pflanzenpräparate-Kombination mit aromatherapeutischen Komponenten, deren Herstellung und Verwendung Soothing Herbal preparations combination with aromatherapeutic components, their preparation and use |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | CA2576544A1 Pyrazolone compounds useful for treatment of cerebrovascular disorders associated with ischemic stroke |
| 02/16/2006 | CA2576405A1 Antibody and utilization of the same |
| 02/16/2006 | CA2576385A1 Novel formulation for l-tryptophane comprising carbidopa/benserazide |
| 02/16/2006 | CA2576258A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 02/16/2006 | CA2576254A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 02/16/2006 | CA2576153A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 02/16/2006 | CA2575980A1 Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor |
| 02/16/2006 | CA2575907A1 Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 02/16/2006 | CA2574827A1 4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 02/16/2006 | CA2573091A1 Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients |
| 02/16/2006 | CA2571407A1 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 02/16/2006 | CA2570324A1 Rage fusion proteins and methods of use |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1626049A1 Microcrystal |
| 02/15/2006 | EP1626043A1 Heterocyclic thioesters |
| 02/15/2006 | EP1625848A1 Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625845A1 Adhesive preparation containing fentanyl |
| 02/15/2006 | EP1625400A1 Method for selecting allosteric regulators of class iii g protein-coupled receptors |
| 02/15/2006 | EP1625213A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
| 02/15/2006 | EP1625152A2 Peptides modulating the activity of the engrailed transcription factor |
| 02/15/2006 | EP1625128A2 Thermal energy storage |
| 02/15/2006 | EP1625125A1 Compounds as crf1 receptor antagonists |
| 02/15/2006 | EP1624936A1 Cns chloride modulation and uses thereof |
| 02/15/2006 | EP1624873A2 Use of tyrosine kinase inhibitors for treating cerebral ischemia |
| 02/15/2006 | EP1624872A2 Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration |
| 02/15/2006 | EP1624867A1 Further therapeutic use of zolpidem |
| 02/15/2006 | EP1624845A2 4',4''-substituted 3alpha-(diphenylmethoxy)tropane analogs for treatment of mental disorders |
| 02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 02/15/2006 | EP1453835B1 Adenosine a 2a receptor antagonists |
| 02/15/2006 | EP1441739B1 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 02/15/2006 | EP1224207B1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 02/15/2006 | EP1076562B1 Glucocorticoid receptor antagonists for the treatment of dementia |
| 02/15/2006 | CN1735619A Spirocyclic cyclohexane compounds |
| 02/15/2006 | CN1735613A 稠合杂环化合物 Fused heterocyclic compounds |
| 02/15/2006 | CN1735610A Oxazoles as mGluR1 enhancer |
| 02/15/2006 | CN1735595A Substituted alkyl amido piperidines |
| 02/15/2006 | CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 02/15/2006 | CN1735441A Combination for the treatment of ADHD |
| 02/15/2006 | CN1735427A Pain relief agents |
| 02/15/2006 | CN1735423A Treatment of gastroparesis |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735407A Methods of using and compositions comprising dopamine reuptake inhibitors |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733704A Synthesis and biological and pharmacological action of betaine salicylate |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1733293A Cerebroside carnosine freeze-dried powder and process for preparing the same |
| 02/15/2006 | CN1733286A Chinese traditional medicine compound preparation for preventing and curing alcoholic intestinal tract and liver injury |
| 02/15/2006 | CN1733270A Medicine composite and process for preparing the same |
| 02/15/2006 | CN1733268A Heat clearing and detoxicating pill containing vomiting nut |
| 02/15/2006 | CN1733267A Chinese traditional medicine preparation for treating mental disease |
| 02/15/2006 | CN1733255A Process for preparing medicine containing gastrodia tuber for curing wind syndrome of head |
| 02/15/2006 | CN1733189A Technique for preparing Yueju capsule and quality control method |
| 02/15/2006 | CN1733167A External applied Chinese traditional medicine plaster for curing facial paralysis and process for preparing the same |
| 02/15/2006 | CN1733143A Aimal liver concentration tablet and technique for preparing the same |
| 02/15/2006 | CN1733131A Schisandra fruit extractive, its preparation process and purposes |
| 02/15/2006 | CN1733107A Medicine for treating coronary disease and apoplexy sequelae and process for preparing the same |
| 02/15/2006 | CN1733081A Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process |
| 02/15/2006 | CN1733033A Acanthopanax dripping pills and its preparation process |
| 02/15/2006 | CN1733021A Novel administering route of pain stopping injection, its preparation process and novel indications |
| 02/15/2006 | CN1732998A Process for preparing film coated brain-invigorating kidney-tonifying pills |
| 02/15/2006 | CN1732995A Chinese medicine for treating neurological disease |
| 02/15/2006 | CN1732981A Alcohol-neutralizing agent composition containing hyaluronic acid |
| 02/15/2006 | CN1732955A Pharmaceutical composition making anemarrhena total sapogenin as active ingredient, its preparation method and use |
| 02/15/2006 | CN1732940A Compound flupentixol and melitracen capsule and preparation process thereof |
| 02/15/2006 | CN1732939A Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer |
| 02/15/2006 | CN1732936A Nimodipine emulsion injection liquid and method for preparing the same |
| 02/15/2006 | CN1732919A Application of bicychol in preparation of medicine for preventing and/or treating acute alcoholism and acute/chronic alcoholic liver injury |